CAS 937270-47-8
:TG02
Description:
TG02, with the CAS number 937270-47-8, is a chemical compound that has garnered attention in various fields, particularly in medicinal chemistry and pharmacology. It is characterized as a small molecule with a specific structure that allows it to interact with biological targets, making it a subject of interest in drug discovery. TG02 is known for its potential role as a modulator of immune responses, particularly in the context of autoimmune diseases and cancer therapies. The compound exhibits properties that may influence cell signaling pathways, thereby affecting cellular proliferation and survival. Its solubility, stability, and bioavailability are critical factors that determine its efficacy in therapeutic applications. Additionally, TG02's safety profile and pharmacokinetics are essential considerations in the development of formulations for clinical use. As research continues, the full spectrum of its characteristics, including its mechanism of action and potential side effects, will be further elucidated, contributing to its understanding and application in medical science.
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 7 products.
(E/Z)-Zotiraciclib
CAS:<p>(E/Z)-Zotiraciclib ((E/Z)-TG02) inhibits CDK2, JAK2, and FLT3 effectively with IC50s of 13, 73, and 56 nM, respectively.</p>Formula:C23H24N4OPurity:97.75% - 99.92%Color and Shape:SolidMolecular weight:372.46SB 1317
CAS:<p>Inhibitor of CDK2, JAK2 and FLT3; anticancer</p>Formula:C23H24N4OPurity:Min. 95%Color and Shape:Off-White PowderMolecular weight:372.46 g/mol
